The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing adoption of this innovative treatment for a range of diseases. Key drivers shaping the market include rising prevalence of cancer, advancements in research, and supportive guidelines. The market is characterized by a fragmented landscape with numerous pla